LIPOSCIENCE INC
DelistedCIK 1168197fmd_126R4J3KH1VWXJRRH3FT3SESFMManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jan 01, 2011 to Sep 30, 2014, 12 periods
| Line item | FY2011 | FY2012 | FY2013 |
|---|---|---|---|
| Cost of revenue | 9 | 10 | 11 |
| Gross profit | 37 | 45 | 42 |
| Research and development | 8 | 10 | 13 |
| Selling, general and administrative | 30 | 33 | 40 |
| Total operating expenses | 38 | 43 | 52 |
| Operating income | (0) | 2 | (11) |
| Interest expense | 0 | 1 | 2 |
| Interest and investment income | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | (0) | (0) |
| Income tax expense | 0 | 0 | 0 |
| Net income | (1) | 1 | (13) |
| Net income to common shareholders | (1) | 0 | (13) |